Lepu Profile

In 2009 Lepu Medical successfully went public, and was listed on Chinext Shenzhen StockExchange Market ( stock code: 300003).

Vision

To build Lepu Medical into a large-scale global company in the cardiovascular industry that provides products and solutions covering prevention, treatment and rehabilitation for the patients with cardiovascular and related diseases.

To develop Lepu Medical into one of the largest supplier of cardiovascular related products and services on the platforms of medical device, medicine, healthcare products, healthcare service and new medical mode.

To set up a comprehensive online and offline service platform for cardiovascular health, and provide Chinese people with omnipresent care all the while.

Current Strategy

To establish the China`s leading industry chain for cardiovascular health with the 4 in 1 platform including medical devices, pharmaceutical, healthcare service and new medical mode.

Subsidiaries

Up until 2016, Lepu Medical has in total 28 primary subsidiaries and 38 secondary subsidiaries worldwide. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery. The following nine subsidiaries are manufacturers with the products for Lepu`s global business.

Lepu -Model C3 -Portable Ultrasound System

Features